CoChat

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Folk, James C., Stone, Edwin M. · 2010 · New England Journal of Medicine
Cited by 91

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

A 66-year-old man presents with a 2-week history of blurred and distorted vision in his right eye. A retinal specialist diagnoses neovascular age-related macular degeneration (AMD) and recommends treatment with ranibizumab.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmct1000495

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 91

Metadata

Authors
Folk, J. C., & Stone, E. M.
Venue
New England Journal of Medicine
Published
2010-10-21
Volume
363
Issue
17
Pages
1648-1655
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1985608223
Cited by
91
References
19
FWCI
9.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. https://app.cochat.ai/papers/10.1056/nejmct1000495
The paper
Folk, J. C., & Stone, E. M. (2010). Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. New England Journal of Medicine. https://doi.org/10.1056/nejmct1000495

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.